E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/19/2006 in the Prospect News Biotech Daily.

Janney Montgomery to lead Viragen's strategy, financing plans

By Lisa Kerner

Erie, Pa., Jan. 19 - Viragen, Inc. said it entered into an investment banking agreement, appointing Janney Montgomery Scott LLC as its financial advisor.

Janney Montgomery will evaluate strategic alternatives, including obtaining additional financing and exploring potential merger and acquisition opportunities to enhance stockholder value, according to a company news release.

Viragen, based in Plantation, Fla., is a biotechnology company engaged in the development, manufacture, and commercialization of pharmaceutical proteins for the treatment of viral diseases and cancers.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.